Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WW domain binding protein 11 pseudogene 1 (WBP11P1) is a human pseudogene related to the protein-coding gene WBP11. As a pseudogene, it does not encode a functional protein and is not known to have any biological function, disease relevance, or therapeutic targeting potential. WBP11P1 is referenced in genetic and genomic databases but is distinguished from the protein-coding gene WBP11, which functions as a component of the spliceosome and is involved in mRNA splicing. No evidence exists for WBP11P1 being a therapeutic target, biomarker, or having related drugs[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain binding protein 11 pseudogene 1 (WBP11P1).